Cancer cells activate lipogenic enzymes, including StearoylCoA Desaturase-1 (SCD1), the key enzyme that converts saturated fatty acids (SFA) into monounsaturated fatty acids (MUFA). Previously, we established that SCD1 regulates lipogenesis, cell proliferation and invasiveness in lung cancer cells, as well as tumor formation in mice. We recently reported that SCD1 modulates the PI3K/Akt pathway, a central signaling cascade, along with ERK, which are involved in the regulation of lipid biosynthesis, growth and survival of mammalian cells. Growth factor-activated tyrosine kinase receptors, such as epidermal growth factor (EGF) receptors (EGFR), are main activators of Akt and ERK signals, two cascades that are most often deranged in cancer. A hallmark of cancer is the metabolic shift towards macromolecular synthesis to support cell replication. SCD1 expression increases in cancer cells. The molecular mechanisms by which SCD1 regulates the biological phenotype of cancer cells is still unknown. The poor prognosis and ineffective treatments of some cancers, such as lung cancer, calls for better understanding of their mechanisms and for finding novel targets that, like SCD1, modulate the Akt and ERK pathways. Here we provide evidence that SCD1 activity controls the activation of EGFR and its downstream signaling targets, Akt and ERK. Using H460 human lung cancer cells, we observed that the activating phosphorylation of Tyr1068 and Tyr1086 residues in EGFR upon EGF stimulation was markedly impaired when SCD1 activity was blocked with CVT-11127, a novel small molecule SCD inhibitor. In addition, supplementation with oleic acid, the product of SCD1, restored EGF-induced phosphorylation of EGFR but not the full phosphorylation of Akt. Finally, abrogation of SCD1 dramatically altered distribution of rafts and non-raft domains, suggesting that the regulation of EGFR function by SCD1 may involve the alteration of membrane lipid domains. All results are representative of 3 separate experiments. In conclusion, our data indicate that SCD1 may coordinate the regulation of lipid biosynthesis and the transduction signals that control cancer cell metabolism, proliferation, survival and tumorigenesis by modulating EGFR activation, which subsequently modifies the Akt and ERK signaling platforms. Our findings also suggest SCD1 is a potential target for novel pharmacological interventions in lung cancer.
Subject (authority = RUETD)
Topic
Nutritional Sciences
RelatedItem (type = host)
TitleInfo
Title
Rutgers University Electronic Theses and Dissertations
Rutgers University. Graduate School - New Brunswick
AssociatedObject
Type
License
Name
Author Agreement License
Detail
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.